Craig L Slingluff, Jr
24 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Excision of Lymph Node Trial (EXCILYNT) (Mel69) (NCT05839912) | Craig L Slingluff, Jr | 2023-09-06 |
| Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) (NCT04364230) | Craig L Slingluff, Jr | 2020-09-28 |
| Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors (NCT04116320) | Craig L Slingluff, Jr | 2019-11-21 |
| Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma (NCT03617328) | Craig L Slingluff, Jr | 2018-11-13 |
Track Craig L Slingluff, Jr automatically
Every clearance here is in the API, with alerts when new ones post.